研究报告 |
|
|
|
|
EV71类病毒颗粒的表达和免疫原性的初步评价 |
郭莉莉, 欧霞, 米锴, 孙茂盛, 李鸿钧 |
云南省重大传染病疫苗工程技术研究中心 云南省重大传染病疫苗研发实验室 昆明 650118 |
|
Expression of Enterovirus 71 VLP in Baculovirus System and Evaluation of Its Immunogenicity |
GUO Li-li, OU Xia, MI Kai, SUN Mao-sheng, LI Hong-jun |
Yunnan Engineering Center of Vaccine Research Development on Severe Infecticus Diseases Yunnan Keylaboratory of Vaccine Research & Development on Severe Infections Diseases, Kunming 650118, China |
引用本文:
郭莉莉, 欧霞, 米锴, 孙茂盛, 李鸿钧. EV71类病毒颗粒的表达和免疫原性的初步评价[J]. 中国生物工程杂志, 2013, 33(1): 8-13.
GUO Li-li, OU Xia, MI Kai, SUN Mao-sheng, LI Hong-jun. Expression of Enterovirus 71 VLP in Baculovirus System and Evaluation of Its Immunogenicity. China Biotechnology, 2013, 33(1): 8-13.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2013/V33/I1/8
|
[1] 陈伟雄.手足口病的最新研究进展及预防措施. 社区医学杂志, 2011,9 (19):10-12. Chen W X. Research advances and prevention measures of hand-foot-mouth disense. JCM, 2011, 9(19):10-12. [2] Ooi M H, Solomon T, Podin Y, et al. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. Journal of Clinical Microbiology, 2007, 45: 1858-1866. [3] Huang C C, Liu C C, Chang Y C, et al. Neurologic complications in children with enterovirus 71 infection.The New England Journal of Medicine, 1999, 341: 936-942. [4] Cardosa M J, Perera D, Brown B A, et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis, 2003, 9:461-468. [5] Yang F, Ren L, Xiong X, et al. Enterovirus 71 outbreak in the people’s republic of china in 2008. J Clin Microbiol, 2009, 47: 2351-2352. [6] 陈宏, 苏俐. 手足口病的研究现状. 现代中西医结合杂志, 2012, 21(2):224-226. Chen X, Su L. Research advances of hand-foot-macth disease. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2012, 21(2):224-226. [7] Li R Q, Chen L J, Wang Y M, et al. Genetic characteristics of enterovirus 71 isolated in Beijing, 2006-2008. Chin J Epidemiol, 2009, 30(1):45-49. [8] Chung Y C, Ho M S, Wu J C, et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine, 2008, 26(15):1855-1862 [9] 郝翊, 秦川. 人肠道病毒71型亚单位疫苗的研制. 中国比较医学杂志, 2010, 20(6): 7-12. Hao Y, Qin C. Preporation of Subcenit vaccine for human enterovirus 71. Chinese Journal of Comparative Medicine, 2010, 20 (6):7-12. [10] Dingmei Zhang, Jiayuan Lu, Jiahai Lu. Enterovirus 71 vaccine: close but still far. International Journal of Infections Diseases, 2010, 14: 739-747. [11] Mcminn P C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev, 2002;26(1):91-107. [12] Brown B A, Oberste M S, Alexander Jr Jp, et al. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol, 1999, 73(12):9969-9975. [13] 曹蕾, 伊瑶, 宋敬东等. 杆状病毒表达EV71病毒颗粒的装配、制备纯化与鉴定. 病毒学报, 2012, 28(3):201-206. Cao L, Yi Y, Song J D, et al. The assuemblage, purification and cheracterization of EV71VIPs expressed in Baculovirus. Chinese Journal of Virology, 2012, 28(3): 201-206. [14] Foo D G, Alonso S, Chow V T, et al. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect, 2007;9:1299-306. [15] Chung Y C, Huang J H, Lai C W, et al. Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol, 2006, 12(6):921-927. [16] 刘拂晓, 柳增善, 王志亮. 杆状病毒表达系统-有效的VLP构建工具. 生物技术通报, 2012:6:25-31. Liu F X, Liu Z S, Wang Z L. Baculevirus expression system-effective tool of VLP procluotion. Biotechnology Bulletin, 2012:6:25-31. [17] 黄任和, 余模松. 测定杆状病毒滴度方法的研究进展. 微生物学免疫学进展, 2007, 35(2):79-83. Huang S H, Yu M S. Research advence of the determiration method for the titer of the baculovirus. Prog in Microbiol Immunol, 2007, 35 (2):79-83. [18] Yao-Chi Chung, Mei-Shang Ho, Yu-Chen Hu, et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine, 2008, 26:1855-1862. [19] Yu-Li Lin, Chun-I Yu, Yu-Chen Hu, et al. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine, 2012, 30:1305-1312. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|